• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?

Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?

by Scott Wallask | Apr 2, 2024 | Inside the Lab Industry-lir, Lab Industry Advisor, Premium

Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Diagnostics Pipeline: FDA Tweaks Quality System Regs to Align with Global Standards

Diagnostics Pipeline: FDA Tweaks Quality System Regs to Align with Global Standards

by Ron Shinkman | Mar 27, 2024 | Clinical Diagnostics Insider, FDA-dtet

The FDA is adding International Organization for Standardization (ISO) guidelines to its “good manufacturing” requirements

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
April 2024 Labs in Court

April 2024 Labs in Court

by Karen Lovitch, David Gilboa | Mar 25, 2024 | Essential, Lab Industry Advisor, Labs in Court

Recent enforcement actions include convictions and guilty pleas for false claims-related allegations involving toxicology labs.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Staying on Top of Medical Necessity and Marketer Compliance

Staying on Top of Medical Necessity and Marketer Compliance

by Danielle H. Tangorre, Seth B. Orkand | Mar 25, 2024 | Compliance Perspectives-lca, Enforcement-lca, Essential, Lab Industry Advisor

Recent enforcement actions show that clinical laboratories must remain vigilant about compliance relating to these areas

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Pandemics: Prediction, Prevention, and Response

Pandemics: Prediction, Prevention, and Response

by Michael Schubert, PhD | Mar 22, 2024 | Clinical Diagnostics Insider, Emerging Tests-dtet, Testing Trends-dtet

Recent efforts to forecast the next infectious disease outbreak and steps labs can take to ensure they’re prepared.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com